Bal Pharma Limited
NSE:BALPHARMA.NS
127.24 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 3,392.196 | 3,042.162 | 2,812.145 | 2,505.286 | 1,710.943 | 2,250.105 | 2,092.877 | 2,289.09 | 1,983.166 | 1,871.573 | 1,788.721 | 1,479.145 | 1,396.866 | 1,142.919 | 1,062.252 | 1,034.778 | 857.35 |
| Kosten van de omzet
| 2,622.001 | 1,727.699 | 1,697.335 | 1,512.252 | 856.045 | 1,203.178 | 1,021.718 | 1,170.736 | 1,079.713 | 992.038 | 952.318 | 789.449 | 768.016 | 615.282 | 600.001 | 532.068 | 428.696 |
| Brutowinst
| 770.195 | 1,314.463 | 1,114.81 | 993.034 | 854.898 | 1,046.927 | 1,071.159 | 1,118.354 | 903.453 | 879.536 | 836.402 | 689.696 | 628.851 | 527.638 | 462.252 | 502.71 | 428.654 |
| Brutowinstmarge
| 0.227 | 0.432 | 0.396 | 0.396 | 0.5 | 0.465 | 0.512 | 0.489 | 0.456 | 0.47 | 0.468 | 0.466 | 0.45 | 0.462 | 0.435 | 0.486 | 0.5 |
| Onderzoek- en ontwikkelingskosten
| 30.32 | 49.194 | 32.039 | 20.245 | 28.306 | 16.412 | 16.415 | 14.752 | 19.374 | 32.71 | 28.076 | 28.61 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 0 | 34.236 | 27.054 | 21.255 | 25.384 | 28.452 | 32.92 | 31.068 | 16.812 | 0 | 28.87 | 20.838 | 0 | 53.2 | 44.973 | 45.261 | 57.847 |
| Verkoop- en marketingkosten
| 0 | 54.058 | 148.169 | 102.69 | 111.052 | 157.376 | 153.155 | 173.623 | 61.815 | 0 | 120.235 | 91.892 | 0 | 175.577 | 185.432 | 195.17 | 156.566 |
| Verkoop-, algemene en administratieve kosten
| 555.626 | 88.294 | 175.223 | 123.945 | 136.436 | 185.828 | 186.075 | 204.691 | 78.627 | 336.133 | 512.406 | 422.026 | 0 | 228.777 | 230.405 | 240.431 | 214.413 |
| Overige kosten
| 28.482 | 9.406 | 17.338 | 7.727 | 9.298 | 0.965 | 1.574 | 830.845 | 744.543 | 775.697 | 705.03 | 0.193 | 0.027 | 225.704 | 205.779 | 175.304 | 141.954 |
| Bedrijfskosten
| 555.626 | 1,154.518 | 967.884 | 822.157 | 881.024 | 929.875 | 965.205 | 1,040.956 | 823.17 | 775.697 | 705.03 | 565.527 | 522.089 | 454.48 | 436.184 | 415.735 | 356.366 |
| Bedrijfsresultaat
| 214.569 | 169.35 | 144.358 | 170.877 | -26.126 | 117.052 | 105.954 | 77.398 | 80.283 | 103.839 | 131.373 | 124.169 | 106.762 | 73.158 | 26.068 | 86.975 | 72.288 |
| Bedrijfsresultaat ratio
| 0.063 | 0.056 | 0.051 | 0.068 | -0.015 | 0.052 | 0.051 | 0.034 | 0.04 | 0.055 | 0.073 | 0.084 | 0.076 | 0.064 | 0.025 | 0.084 | 0.084 |
| Totaal overige inkomsten en kosten netto
| -124.095 | -121.865 | -52.533 | -129.85 | -109.167 | -119.077 | -77.124 | -53.79 | -53.789 | -56.434 | -65.113 | -73.278 | -62.21 | -62.776 | -35.111 | -46.418 | -30.258 |
| Inkomen voor belasting
| 90.474 | 47.485 | 91.825 | 41.027 | -135.293 | -2.025 | 28.83 | 23.608 | 26.495 | 47.405 | 66.26 | 50.891 | 44.551 | 10.381 | -9.043 | 40.557 | 42.03 |
| Inkomen voor belasting ratio
| 0.027 | 0.016 | 0.033 | 0.016 | -0.079 | -0.001 | 0.014 | 0.01 | 0.013 | 0.025 | 0.037 | 0.034 | 0.032 | 0.009 | -0.009 | 0.039 | 0.049 |
| Belastingkosten
| 16.016 | 21.292 | 34.775 | -6.095 | -6.376 | -23.554 | 25.065 | 30.98 | 23.9 | 11.874 | 15.537 | 8.056 | 6.982 | 6.303 | 5.226 | 10.628 | 13.458 |
| Nettowinst
| 73.922 | 25.718 | 56.115 | 47.423 | -122.182 | 37.879 | 27.822 | 19.86 | 14.054 | 36.279 | 50.723 | 42.835 | 37.569 | 4.079 | -14.288 | 29.929 | 28.571 |
| Nettowinstmarge
| 0.022 | 0.008 | 0.02 | 0.019 | -0.071 | 0.017 | 0.013 | 0.009 | 0.007 | 0.019 | 0.028 | 0.029 | 0.027 | 0.004 | -0.013 | 0.029 | 0.033 |
| WPA (Winst Per Aandeel)
| 4.94 | 1.64 | 3.79 | 3.34 | -8.62 | 2.67 | 1.96 | 1.24 | 1.09 | 2.83 | 4.77 | 4.05 | 3.57 | 0.45 | -1.36 | 2.85 | 2.74 |
| Verwaterde WPA
| 4.94 | 1.64 | 3.71 | 3.34 | -8.62 | 2.67 | 1.96 | 1.24 | 1.09 | 2.8 | 4.6 | 4.05 | 3.57 | 0.45 | -1.36 | 2.85 | 2.65 |
| EBITDA
| 315.28 | 260.633 | 244.879 | 242.176 | 48.877 | 167.858 | 180.679 | 157.381 | 145.333 | 168.534 | 178.769 | 172.289 | 139.289 | 107.851 | 41.049 | 111.935 | 91.433 |
| EBITDA ratio
| 0.093 | 0.086 | 0.087 | 0.097 | 0.029 | 0.075 | 0.086 | 0.069 | 0.073 | 0.09 | 0.1 | 0.116 | 0.1 | 0.094 | 0.039 | 0.108 | 0.107 |